-
Something wrong with this record ?
Cardiotonic steroids as potential Na+/K+-ATPase inhibitors - a computational study
CN. Patel, SP. Kumar, KM. Modi, MN. Soni, NR. Modi, HA. Pandya,
Language English Country Great Britain
Document type Journal Article
- MeSH
- Models, Biological MeSH
- Diffusion MeSH
- Digoxin chemistry pharmacology MeSH
- Quantitative Structure-Activity Relationship MeSH
- Ligands MeSH
- Ouabain chemistry pharmacology MeSH
- Reproducibility of Results MeSH
- Molecular Docking Simulation * MeSH
- Sodium-Potassium-Exchanging ATPase antagonists & inhibitors metabolism MeSH
- Cardiac Glycosides pharmacology MeSH
- Hydrogen Bonding MeSH
- Publication type
- Journal Article MeSH
Cardiotonic steroids (CTS) are steroidal drugs, processed from the seeds and dried leaves of the genus Digitalis as well as from the skin and parotid gland of amphibians. The most commonly known CTS are ouabain, digoxin, digoxigenin and bufalin. CTS can be used for safer medication of congestive heart failure and other related conditions due to promising pharmacological and medicinal properties. Ouabain isolated from plants is widely utilized in in vitro studies to specifically block the sodium potassium (Na+/K+-ATPase) pump. For checking, whether ouabain derivatives are robust inhibitors of Na+/K+-ATPase pump, molecular docking simulation was performed between ouabain and its derivatives using YASARA software. The docking energy falls within the range of 8.470 kcal/mol to 7.234 kcal/mol, in which digoxigenin was found to be the potential ligand with the best docking energy of 8.470 kcal/mol. Furthermore, pharmacophore modeling was applied to decipher the electronic features of CTS. Molecular dynamics simulation was also employed to determine the conformational properties of Na+/K+-ATPase-ouabain and Na+/K+-ATPase-digoxigenin complexes with the plausible structural integrity through conformational ensembles for 100 ns which promoted digoxigenin as the most promising CTS for treating conditions of congestive heart failure patients.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005924
- 003
- CZ-PrNML
- 005
- 20200525141103.0
- 007
- ta
- 008
- 200511s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/10799893.2019.1660893 $2 doi
- 035 __
- $a (PubMed)31509043
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Patel, Chirag N $u Department of Botany, Bioinformatics and Climate Change Impacts Management, University School of Science, Gujarat University , Ahmedabad , India.
- 245 10
- $a Cardiotonic steroids as potential Na+/K+-ATPase inhibitors - a computational study / $c CN. Patel, SP. Kumar, KM. Modi, MN. Soni, NR. Modi, HA. Pandya,
- 520 9_
- $a Cardiotonic steroids (CTS) are steroidal drugs, processed from the seeds and dried leaves of the genus Digitalis as well as from the skin and parotid gland of amphibians. The most commonly known CTS are ouabain, digoxin, digoxigenin and bufalin. CTS can be used for safer medication of congestive heart failure and other related conditions due to promising pharmacological and medicinal properties. Ouabain isolated from plants is widely utilized in in vitro studies to specifically block the sodium potassium (Na+/K+-ATPase) pump. For checking, whether ouabain derivatives are robust inhibitors of Na+/K+-ATPase pump, molecular docking simulation was performed between ouabain and its derivatives using YASARA software. The docking energy falls within the range of 8.470 kcal/mol to 7.234 kcal/mol, in which digoxigenin was found to be the potential ligand with the best docking energy of 8.470 kcal/mol. Furthermore, pharmacophore modeling was applied to decipher the electronic features of CTS. Molecular dynamics simulation was also employed to determine the conformational properties of Na+/K+-ATPase-ouabain and Na+/K+-ATPase-digoxigenin complexes with the plausible structural integrity through conformational ensembles for 100 ns which promoted digoxigenin as the most promising CTS for treating conditions of congestive heart failure patients.
- 650 _2
- $a srdeční glykosidy $x farmakologie $7 D002301
- 650 _2
- $a difuze $7 D004058
- 650 _2
- $a digoxin $x chemie $x farmakologie $7 D004077
- 650 _2
- $a vodíková vazba $7 D006860
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a biologické modely $7 D008954
- 650 12
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a ouabain $x chemie $x farmakologie $7 D010042
- 650 _2
- $a kvantitativní vztahy mezi strukturou a aktivitou $7 D021281
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a sodíko-draslíková ATPasa $x antagonisté a inhibitory $x metabolismus $7 D000254
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kumar, Sivakumar Prasanth $u Molecular Biophysics Unit, Indian Institute of Science , Bangalore , India.
- 700 1_
- $a Modi, Krunal M $u J. Heyrovský Institute of Physical Chemistry, Academy of Sciences of the Czech Republic , Dolejškova , Czech Republic.
- 700 1_
- $a Soni, Mehul N $u Department of Botany, Bioinformatics and Climate Change Impacts Management, University School of Science, Gujarat University , Ahmedabad , India.
- 700 1_
- $a Modi, Nainesh R $u Department of Botany, Bioinformatics and Climate Change Impacts Management, University School of Science, Gujarat University , Ahmedabad , India.
- 700 1_
- $a Pandya, Himanshu A $u Department of Botany, Bioinformatics and Climate Change Impacts Management, University School of Science, Gujarat University , Ahmedabad , India.
- 773 0_
- $w MED00004942 $t Journal of receptor and signal transduction research $x 1532-4281 $g Roč. 39, č. 3 (2019), s. 226-234
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31509043 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200525141102 $b ABA008
- 999 __
- $a ok $b bmc $g 1524782 $s 1095980
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 39 $c 3 $d 226-234 $e 20190911 $i 1532-4281 $m Journal of receptor and signal transduction research $n J Recept Signal Transduct Res $x MED00004942
- LZP __
- $a Pubmed-20200511